Pharming Group, N.V.
(NASDAQ: PHAR)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $8.43 | Change: +0.38 | %Change: +4.72% | Volume: 420 |
Open: | $ 8.43 | Volume: | 420 | |
---|---|---|---|---|
High: | $ 8.43 | Yield(%) | 0.00 | |
Low: | $ 8.43 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 542.12M | |
EPS ($) | -0.15 | Shares Out: | 67.34M |
% Price Change (last 4 weeks): | -8.00 |
---|---|
% Price Change (last 13 weeks): | -25.19 |
% Price Change (last 26 weeks): | -30.01 |
% Price Change (last 52 weeks): | -27.79 |
% Price Change (year to date): | -29.57 |
Return on Equity (%): | -4.99 |
---|---|
Return on Assets (%): | -2.34 |
Return on Invested Capital (%): | 11.26 |
Gross Profit Margin (%): | 85.23 |
---|---|
Net Profit Margin (%): | -4.30 |
Operating Profit Margin (%): | -8.98 |
|
|
50-day Moving Average: | $9.04 |
---|---|
200-day Moving Average: | $9.96 |
Avg. Daily Vol. (last 50 days): | 5,391 |
Avg. Daily Vol. (last 200 days): | 3,648 |
52-wk high: | $16.71 |
52-wk low: | $6.97 |
Bid: | $8.06 |
Ask: | $8.50 |
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
|
Pharming Group, N.V.
Darwinweg 24 Leiden ZH 2333 CR Phone: 31.71.524.74.00 Fax: n/a http://www.pharming.com |
Earnings (1year) ($): | -0.15 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 3.26 |
Cash Flow ($): | 0.01 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 3.06 |
Price/Book (x): | 3.51 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.33 |
---|---|
Current Ratio (x): | 4.06 |
LT Debt/Equity (x): | 75.92 |
Total Debt/Equity (x): | 78.41 |